BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17601496)

  • 1. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
    Hashimoto K; Ishima T; Fujita Y; Matsuo M; Kobashi T; Takahagi M; Tsukada H; Iyo M
    Biol Psychiatry; 2008 Jan; 63(1):92-7. PubMed ID: 17601496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
    Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
    Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
    Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
    Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7 nicotinic receptor agonism mitigates phencyclidine-induced changes in synaptophysin and Arc gene expression in the mouse prefrontal cortex.
    Thomsen MS; Hansen HH; Mikkelsen JD
    Neurochem Int; 2010 Dec; 57(7):756-61. PubMed ID: 20817066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
    Hashimoto K; Fujita Y; Iyo M
    Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
    Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
    Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.
    Barak S; Arad M; De Levie A; Black MD; Griebel G; Weiner I
    Neuropsychopharmacology; 2009 Jun; 34(7):1753-63. PubMed ID: 19158670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.
    Fujita Y; Ishima T; Kunitachi S; Hagiwara H; Zhang L; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):336-9. PubMed ID: 17884273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
    Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
    Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
    Tanibuchi Y; Fujita Y; Kohno M; Ishima T; Takatsu Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):861-7. PubMed ID: 19656663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.
    Kjaerby C; Bundgaard C; Fejgin K; Kristiansen U; Dalby NO
    Neuropharmacology; 2013 Sep; 72():157-68. PubMed ID: 23643744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
    Horio M; Fujita Y; Hashimoto K
    Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
    Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():204-12. PubMed ID: 26519556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.